G-Protein Coupled Receptor Targeting Market

G protein?coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein?linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
G-Protein Coupled Receptor Targeting Market contains market size and forecasts of G-Protein Coupled Receptor (GPCR) Targeting in global, including the following market information:
Global G-Protein Coupled Receptor (GPCR) Targeting Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global G-Protein Coupled Receptor (GPCR) Targeting Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five G-Protein Coupled Receptor (GPCR) Targeting companies in 2021 (%)
The global G-Protein Coupled Receptor (GPCR) Targeting market was valued at 91 million in 2021 and is projected to reach US$ 107.5 million by 2028, at a CAGR of 2.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GPCR Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of G-Protein Coupled Receptor (GPCR) Targeting include Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam and Corning, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the G-Protein Coupled Receptor (GPCR) Targeting manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global G-Protein Coupled Receptor (GPCR) Targeting Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global G-Protein Coupled Receptor (GPCR) Targeting Market Segment Percentages, by Type, 2021 (%)
GPCR Consumables
GPCR Equipment
Global G-Protein Coupled Receptor (GPCR) Targeting Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global G-Protein Coupled Receptor (GPCR) Targeting Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiovascular System
Central Nervous System
Other
Global G-Protein Coupled Receptor (GPCR) Targeting Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global G-Protein Coupled Receptor (GPCR) Targeting Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies G-Protein Coupled Receptor (GPCR) Targeting revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies G-Protein Coupled Receptor (GPCR) Targeting revenues share in global market, 2021 (%)
Key companies G-Protein Coupled Receptor (GPCR) Targeting sales in global market, 2017-2022 (Estimated), (K MT)
Key companies G-Protein Coupled Receptor (GPCR) Targeting sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
PerkinElmer
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Cisbio
Discoverx
Enzo Life Sciences